Phibro Animal Health Corporation - Class A Common Stock (PAHC)
41.15
-0.96 (-2.28%)
NASDAQ · Last Trade: Nov 5th, 5:45 PM EST
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · August 28, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · August 28, 2025
Via Benzinga · August 28, 2025
Discover how Phibro Animal Health (PAHC) combines strong technical trends with accelerating earnings and revenue growth, signaling a potential high-momentum investment.
Via Chartmill · November 4, 2025
Phibro Animal Health (PAHC) stock shows strong technical & fundamental momentum, meeting Minervini's Trend Template with high growth in earnings and sales.
Via Chartmill · September 4, 2025
Via Benzinga · August 28, 2025
Via Benzinga · August 28, 2025
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.
Via Benzinga · August 28, 2025
Via Benzinga · August 28, 2025
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.
Via Benzinga · August 28, 2025
Via Benzinga · August 14, 2025
Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
Via Benzinga · July 7, 2025
Via Benzinga · July 7, 2025
Via Benzinga · July 7, 2025

Novartis ranks No. 1 among in the 33-stock Medical-Ethical Drugs industry group. Novartis got a Composite Rating upgrade to 96 on Wednesday.
Via Investor's Business Daily · March 5, 2025

Highly ranked Novartis is forming the right side of a long cup base with a buy point of 120.92. And it's literally running higher.
Via Investor's Business Daily · March 4, 2025

Via Benzinga · December 24, 2024
